MAXIVAX
MaxiVAX is a Swiss clinical-stage biotechnology company, currently performing a first-in-man (phase I) trial in various tumours with MVX-ONCO-1. MaxiVAX’ mission is to develop alternative solutions to “established cancer therapies” that are more effective, are personalized and enable the patient to fight his own disease. MaxiVAX’ first treatment, MVX-ONCO-1 has been classified as an Advanced Therapeutic Product by the European Medicines Agency. The resulting approval procedure is different than that of a traditional drug and should generally allow a faster development until market approval with fewer and less extensive clinical trials.
MAXIVAX
Social Links:
Industry:
Biotechnology
Founded:
2005-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.maxivax.ch
Total Employee:
1+
Status:
Active
Contact:
+41 22 552 26 13
Total Funding:
8.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.maxivax.ch Semrush global rank: 5.19 M Semrush visits lastest month: 1.56 K
- Host name: h2web48.infomaniak.ch
- IP address: 128.65.195.87
- Location: Satigny Switzerland
- Latitude: 46.2146
- Longitude: 6.0355
- Timezone: Europe/Zurich
- Postal: 1242
